By Local Government Association (2014)
Public health made the formal transfer to local government in April 2013, with the hope of tackling the wider social and economic determinants of poor health. This publication aims to capture the thoughts of those working in the new system with contributions from councillors, directors of public health, providers, commissioners, GPs, academics and other key decision makers.
By Macmillan Cancer Support (2014)
This report examines issues that matter most to cancer patients and reveals that tens of thousands of UK cancer patients are diagnosed too late, shown a lack of compassion, or denied a ‘good’ death.
By Macmillan Cancer Support (2014)
This report finds that there is a large variation in survival and the long-term impact on survivors’ health for breast, prostate, lung and brain cancers. It urges NHS leaders and GPs to adopt the solutions in the report and use the research to better plan cancer services. These include improving early diagnosis; providing equal access to the best available treatment; implementing the ‘cancer recovery package’; and encouraging people with cancer to be physically active.
By Department of Health (2014)
As well as presenting data and evidence, the report also comments on overarching trends. This year, information in the report suggests that we may need to rethink what is regarded as ‘normal’ in relation to our health and our society. Some of the main themes discussed in the report are obesity, national data on blindness and deafness and active travel.
By RAND Europe (2014)
Public Health England (PHE) commissioned RAND Europe to undertake a horizon scanning study exploring the future of public health and related scientific services. This work was intended to help inform thinking at the strategic level within PHE, firstly in relation to the wider vision of the Agency and, secondly, in relation to the proposals for the creation of an integrated public health science hub. The report focuses on the different future public health science needs and the extent to which an integrated science hub could serve PHE as it evolves over the next twenty years.
By NICE (February 2014)
This quality standard covers the provision of all aspects of cancer services for children and young people with cancer. For this quality standard, children are defined as aged 0–15 years and young people as 16–24 years, though this is not a formal upper age limit because the needs and circumstances of individuals will vary, including their need to access age-specific services.
By NHS England (2014)
Mapping the Market II: Commissioning Support Services, is a sixty-page report that showcases services for clinical commissioners offered by voluntary sector organisations (VSOs) and small and medium enterprises (SMEs).
The publication, launched at a reception at the NHS Expo in Manchester, contains 12 in-depth interviews with VSO leaders from charities such as MacMillan Cancer Support, Alzheimer’s Society and Turning Point.
It also features a further 15 interviews with SME leaders from organisations such as Dr. Associates and Outcomes Based Healthcare, resulting in the most up-to-date and comprehensive guide to the commissioning support market for anyone involved in commissioning healthcare in the UK.
By Roy Castle Lung Cancer Foundation (2014)
This report analyses the importance of the National Lung Cancer Audit, which was launched in 1994 and captures up to date information on almost every lung cancer case in the UK. It compares clinical practice at hospitals across the country, helping to identify problem areas and drive up standards of care for the disease, which kills 35,000 people every year. This report credits the audit with increasing the number of patients who receive radiotherapy, increasing the number of patients who have surgery, increasing the number of patients who have chemotherapy and increasing the number of patients who see a nurse specialist.
By NHS Improving Quality (2013)
The incidence of cancer in England is increasing, but so are survival rates. By 2030 there are likely to be over 3 million people in England living with or beyond their cancer (National Cancer Survivorship Initiative 2012). As a result, there is growing demand for cancer aftercare services. Routine 1- to 5-year follow-up of cancer survivors within the NHS costs approximately £250 million a year from an annual £6 billion budget.
By Department of Health (2013)
This annual report discusses significant developments in cancer screening; activity to promote earlier diagnosis of symptomatic cancers; progress in ensuring better access for all to the best possible treatment; and significant developments in the collection and reporting of new datasets and the analysis of information to drive improvements and inform patients.